You can be on Entrepreneur’s cover!

Popular Appetite Suppressant Ozempic Can Be Made For Less Than $5 a Month, New Research Suggests The $5 includes a profit margin.

By Sherin Shibu

Key Takeaways

  • Ozempic maker Novo Nordisk A/S charges almost $1,000 per month for the drug in the U.S.
  • A recent study suggests that the price could be lowered to a fraction of the current cost, while still bringing in revenue.
  • Ozempic sales brought in more than $13 billion last year, according to figures reported in the company's 2023 annual report.
entrepreneur daily

Ozempic, the appetite-suppressing injection also known as semaglutide, currently costs $935.77 in the U.S. without insurance. But a new research report from Yale University, King's College Hospital in London, and Doctors Without Borders published in JAMA Network Open Wednesday suggests that the price of the prescription drug could be lowered to a fraction of what it is right now, while still generating a profit.

The researchers calculated cost-based prices for one month of Ozempic, administered as an injectable of 0.77 mg weekly, by combining commercial trade shipment data from January 1, 2016 to March 31, 2023 with the cost of creating the drug, other operating expenses, a profit margin, and tax. They found that the cost-based prices of Ozempic ranged from $0.89 to $4.73 per month.

"The findings of this study suggest that insulins, SGLT2Is, and GLP1As can likely be manufactured for prices far below current prices, enabling wider access," the researchers wrote.

A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication. Photographer: George Frey/Bloomberg via Getty Images

Ozempic costs less outside of the U.S. — a Bloomberg report found that a month's supply of the injectable costs under $300 in Mexico.

"Outside the US, countries have different regulatory requirements with regard to the pricing of medicines, including negotiating with respective government entities," Ozempic maker Novo Nordisk told Bloomberg.

Related: FDA Has Seized 'Thousands' of Fake Units of Ozempic Amid Reported Cases of 'Adverse Reactions' in Patients

Drug markups have long come under national scrutiny, with Martin Shkreli, the former head of Turing Pharmaceuticals, forced to pay $64 million in 2022 after inflating the price of a life-saving drug by 4,000%.

Ozempic falls under the category of a GLP-1 drug, meaning that it addresses type 2 diabetes by improving blood sugar control and also potentially leading to weight loss, according to the Mayo Clinic.

Prescriptions of GLP-1 drugs increased by 300% between 2020 and 2022, Trilliant Health researchers found. Ozempic first made headlines in 2021 when it was featured on the Dr. Oz Show.

Related: Novo Nordisk, the Maker of Ozempic, Is Suing Spas and Clinics For Allegedly Selling Knockoffs

Ozempic and other similar drugs could cause an average weight loss of 15% to 20%, "significantly higher than previous options," as per Columbia Surgery.

The same publication warns of the life-long commitment Ozempic requires, as discontinuing the drug could lead to gaining all of the weight back. The drug could also cause nausea, cramps, and other unpleasant side effects.

Despite the high cost and potential downsides, Ozempic skyrocketed in popularity last year, with 66% of its more than $13 billion sales coming from the US, according to Novo Nordisk's 2023 annual report.

Related: Novo Nordisk Is Worth More Than Denmark's GDP Thanks to America's Ozempic and Wegovy Craze

Sherin Shibu

Entrepreneur Staff

News Reporter

Sherin Shibu is a business news reporter at She previously worked for PCMag, Business Insider, The Messenger, and ZDNET as a reporter and copyeditor. Her areas of coverage encompass tech, business, strategy, finance, and even space. She is a Columbia University graduate.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Resumes & Interviewing

Build a Better Resume with This $35 Subscription

AI Resume Builder promises to help you apply to jobs twice as fast.

Side Hustle

He Took His Side Hustle Full-Time After Being Laid Off From Meta in 2023 — Now He Earns About $200,000 a Year: 'Sweet, Sweet Irony'

When Scott Goodfriend moved from Los Angeles to New York City, he became "obsessed" with the city's culinary offerings — and saw a business opportunity.


I Got Over 225,000 Views in Just 3 Months With Short-Form Video — Here's Why It's the New Era of Marketing

Thanks to our new short-form video content strategy, we've amassed over 225,000 video views in just three months. Learn how to increase brand awareness through short-form video content.

Business News

Samsung Makes 6 Day Workweeks Mandatory for Executives as the Company Enters 'Emergency Mode'

Samsung said its performance "fell short of expectations" last year. Now executives are required to work weekends.


6 Habits That Help Successful People Maximize Their Time

There aren't enough hours in the day, but these tips will make them feel slightly more productive.


You Won't Have a Strong Leadership Presence Until You Master These 5 Attributes

If you are a poor leader internally, you will be a poor leader externally.